Additionally, underexpression of RBM5 and overexpression of KRAS in pancreatic cancer has a close association with metastasis and invasion-related clinicopathological features, suggesting their collaboration in prompting tumor ability of invasion and metastasis. The gene discussed is RBM5; the disease is pancreatic neoplasm.